首页|儿童医院提高抗菌药物治疗前病原学送检专项行动实施的效果

儿童医院提高抗菌药物治疗前病原学送检专项行动实施的效果

扫码查看
目的 评价提高抗菌药物治疗前病原学送检专项行动实施的效果.方法 选择2020年10月1日-2023年9月30日复旦大学附属儿科医院收治的治疗性使用抗菌药物的住院患者及医院感染患者为研究对象,其中2020年10月1日-2021年9月30日为实施前阶段,2021年10月1日-2022年9月30日为实施后第一阶段,2022年10月1日-2023年9月30日为实施后第二阶段.观察项目实施前后抗菌药物治疗前病原学送检率、医院感染诊断相关病原学送检率及联合使用重点药物治疗前病原学送检率等三项指标、抗菌药物使用强度以及耐碳青霉烯类肺炎克雷伯菌(CRKP)、耐碳青霉烯类大肠埃希菌(CRECO)、耐碳青霉烯类阴沟肠杆菌(CRECL)、耐碳青霉烯类铜绿假单胞菌(CRPAE)、耐碳青霉烯类鲍氏不动杆菌(CRAB)、耐甲氧西林金黄色葡萄球菌(MRSA)的检出率.结果 实施前、实施后第一阶段、实施后第二阶段:抗菌药物治疗前病原学送检率分别为66.61%、77.29%、73.89%;医院感染诊断相关病原学送检率分别为79.09%、86.51%、95.76%;联合使用重点抗菌药物治疗前病原学送检率分别为90.84%、91.47%、94.29%;CRPAE检出率在研究期间逐年降低(25.77%、16.41%、15.48%)(P均<0.05),CRKP检出率均较项目实施前增加(13.30%、29.20%、24.19%)(P均<0.05);医院感染相关MRSA比例由项目实施前10.80%降至3.15%(P<0.05),CRECL由55.00%降至10.53%(P<0.05);研究期间抗菌药物使用强度分别为24.82、24.19、26.33.结论 项目实施后病原学送检率三项指标均提高,部分目标耐药菌检出率及医院感染来源比例降低.
Effectiveness of specific project implementation for improving rate of etiological detection in a children's hospital before antibiotic therapy
OBJECTIVE To improve the effectiveness of the implementation of a specific project for pre-treatment pathogenetic delivery of antimicrobial drugs.METHODS Inpatients admitted for therapeutic use of antimicrobial drugs and patients with hospital-acquired infections at the Pediatric Hospital of Fudan University between Oct.2020 and Sep.2023 were selected as the study subjects,of which the period of Oct.1,2020 to Sep.30,2021 was the pre-implementation stage,the period of Oct.1,2021 to Sep.30 was the first stage of post-implementation,and the period of Oct.1 2022 to Sep.30 2023 was the second stage of post-implementation.Three indicators,in-cluding the rate of antimicrobial drug pre-treatment pathogenesis,the rate of nosocomial infection diagnosis-relat-ed pathogenesis,and the rate of combined use of key drugs pre-treatment pathogenesis,the intensity of the use of antimicrobial drugs,as well as the detection rates of carbapenem resistant Klebsiella pneumoniae(CRKP),Esch-erichia coli(CRECO),Enterobacter cloacae(CRECL),Pseudomonas aeruginosa(CRPAE),Acinetobacter bau-mannii(CRAB),methicillin-resistant Staphylococcus aureus(MRSA)before and after the implementation of the project were observed.RESULTS Before antibacterial therapy,in the first stage of post-implementation and the second stage of post-implementation,the rates of pre-treatment pathogenetic delivery of antimicrobial drug were 66.61%,77.29%and 73.89%,respectively;the nosocomial infection diagnosis-related etiological detection rates was 79.09%,86.51%,and 95.76%,respectively;and the rates of pre-treatment pathogenetic delivery of key anti-microbial drugs for combined use were was 90.84%,91.47%,and 94.29%,respectively;the detection rates of CRPAE decreased year by year during the study period,which were 25.77%,16.41%and 15.48%(P<0.05),and the detection rates of CRKP increased significantly compared with those before the implementation of the pro-ject(13.30%,29.20%and 24.19%)(P<0.05).The proportion of nosocomial infection-related MRSA decreased from 10.80%before the implementation of the project to 3.15%(P<0.05),CRECL decreased from 55.00%to 10.53%(P<0.05).During the study period,the antimicrobial use density was 24.82,24.19 and 26.33,respec-tively.CONCLUSION After the implementation of the project,the three indicators of etiological detection rate were improved,and the detection rate of some target drug-resistant bacteria and the proportion of nosocomial in-fection sources were reduced.

Etiological detection rateInterventionMultidrug-resistant bacteriaChildren's hospital

卢露、殷丽军、王能里、翟倩、武娜娜、付盼、李智平、王传清、马健

展开 >

国家儿童医学中心,复旦大学附属儿科医院感染控制与防保科,上海 201102

国家儿童医学中心,复旦大学附属儿科医院肝病科,上海 201102

国家儿童医学中心,复旦大学附属儿科医院新生儿科,上海 201102

国家儿童医学中心,复旦大学附属儿科医院临床检验中心细菌室,上海 201102

国家儿童医学中心,复旦大学附属儿科医院药剂科,上海 201102

国家儿童医学中心,复旦大学附属儿科医院重症医学科,上海 201102

展开 >

病原学送检率 干预措施 多药耐药菌 儿童医院

2024

中华医院感染学杂志
中华预防医学会 中国人民解放军总医院

中华医院感染学杂志

CSTPCD北大核心
影响因子:1.885
ISSN:1005-4529
年,卷(期):2024.34(23)